Norethindrone Acetate (Barr Laboratories Inc.)
Welcome to the PulseAid listing for the Norethindrone Acetate drug offered from Barr Laboratories Inc.. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Barr Laboratories Inc. |
NON-PROPRIETARY NAME: | Norethindrone Acetate |
SUBSTANCE NAME: | NORETHINDRONE ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2001-06-29 |
END MARKETING DATE: | 0000-00-00 |
Norethindrone Acetate HUMAN PRESCRIPTION DRUG Details:
Item Description | Norethindrone Acetate from Barr Laboratories Inc. |
LABELER NAME: | Barr Laboratories Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2001-06-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0555-0211_91cc7e15-8266-4020-a3f0-652dca1cab68 |
PRODUCT NDC: | 0555-0211 |
APPLICATION NUMBER: | ANDA075951 |
Other NORETHINDRONE ACETATE Pharmaceutical Manufacturers / Labelers: